FOSL1 and neoplasm: Most likely, the existence of a NF1-MAPK-FOSL1 axis goes beyond GBM pathogenesis since FOSL1 appears to be upregulated in concomitance with NF1 mutations in multiple tumor types (Figure 8—figure supplement 1).